# Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients

> **NCT01328522** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 32 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** SAR153191 (REGN88)

## Key facts

- **NCT ID:** NCT01328522
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2011-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328522, "Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01328522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*